Looking for our Business Solutions? Click here:CloudQuote APIsContact Us

Kailera Therapeutics, Inc. - Common stock (KLRA)

24.70
+0.44 (1.81%)
NASDAQ · Last Trade: May 6th, 5:19 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
A Kailera Therapeutics (KLRA) Insider Scooped up an Additional 500,000 Shares for $8.0 Millionfool.com
Kailera Therapeutics, a clinical-stage biotech focused on obesity treatments, just reported a notable insider buy in recent SEC filings.
Via The Motley Fool · April 27, 2026